Mode
Text Size
Log in / Sign up

Autologous patch versus secondary intent healing for Mohs surgery woundsThis patch could speed healing after skin cancer surgery

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Consider that an autologous patch showed no clear advantage over secondary intent healing for full epithelialization after Mohs surgery.

This randomized controlled trial enrolled 22 patients undergoing Mohs micrographic surgery. The intervention was an autologous patch, and the comparator was secondary intent healing. The primary outcome was fully epithelialized wounds on day 19. One wound in the patch group and one wound in the control group were fully epithelialized. Wound area reduction was higher in the patch group but was not significant. Transepidermal water loss decreased to a larger extent in the patch group. The Patient and Observer Scar Assessment Scale was evaluated at 6 months, but specific results were not reported.

Safety and tolerability were not formally reported, but patch healing appears safe. Key limitations include that wound area reduction was not significant and reflectance confocal microscopy was applied exploratively. The follow-up duration was 6.0 months. The sample size was small, and p-values and confidence intervals were not reported.

Practice relevance is restrained; secondary intent healing is a viable option, and an autologous patch may prompt benefits in certain wound healing factors. The evidence is early and uncertain, and the intervention should not be considered a proven standard.

Maria, 68, sat in the dermatologist’s office, heart pounding. The doctor had just removed a small patch of skin cancer from her nose using Mohs surgery. Now came the hard part: waiting weeks for the wound to heal on its own. It itched. It oozed. She worried about infection. And she dreaded the scar.

She’s not alone. Thousands of people undergo Mohs micrographic surgery each year to remove skin cancers from the face. The procedure is precise. But healing? That part hasn’t changed much in decades. Wounds are left open to heal slowly over time. It can take weeks. The skin is fragile. Scarring is common.

Most people just have to wait.

But here’s the twist: what if we could help the body heal faster—using something already inside us?

A patch made from your own blood

Doctors have long relied on secondary intent healing. That means no stitches. No grafts. The wound closes naturally. It works. But it’s slow. And it carries risks. Infection. Poor scarring. Dry, cracked skin during recovery.

Now, a small but promising study suggests a simple upgrade: a patch made from the patient’s own blood.

Think of it like a natural bandage built from your body’s healing tools. When blood clots, it forms a mesh that helps seal wounds. This patch uses that same idea. It’s made by spinning a small sample of the patient’s blood to concentrate healing proteins and platelets. Then it’s shaped into a thin sheet and placed directly on the wound.

It acts like a mini healing factory. It keeps the wound moist. It protects new skin cells. And it may give the body a head start.

Healing with less dryness

The study tested this patch in 22 patients after Mohs surgery. Each had one wound treated with the patch. The other healed the usual way. Researchers checked progress at 12 and 19 days. They looked at how much new skin had formed. They measured moisture loss through the skin. And they checked scars after six months.

The patch didn’t make wounds fully close by day 19—that was the main goal. Both groups had just one fully healed wound. But the patch group showed stronger signs of healing.

By day 12, wounds with the patch were healing faster. They had reduced transepidermal water loss. That means less moisture escaped from the skin. Dry skin slows healing. Moist skin supports it. The patch helped keep that balance.

Patients also reported high satisfaction. They liked how the patch felt. It stayed in place. It didn’t cause pain or infection.

But there’s a catch

This doesn’t mean this treatment is available yet.

The study was small. Only 22 people. And the patch didn’t meet the main goal of full healing by day 19. That means it’s not proven to speed closure. But it did improve other key factors—like skin moisture and patient comfort.

Experts say that matters. Healing isn’t just about speed. It’s about quality. A moist wound bed means better tissue repair. Less scarring. Fewer complications.

This patch may not replace current methods. But it could become a helpful add-on—especially for sensitive areas like the face.

What this means for patients

If you’ve had Mohs surgery, you know the drill. You wait. You protect the wound. You hope for the best.

This patch won’t be in clinics tomorrow. But it’s a sign that smarter healing is possible.

You don’t need a donor. No synthetic materials. Just your own blood. That lowers the risk of reaction. And it’s made during the same visit.

Talk to your dermatologist if you’re curious. Ask whether new healing options are being tested near you. For now, standard care is still the norm.

Small study, early but promising results

The trial had limits. It was small. It only looked at short-term healing. And it didn’t test the patch on larger or deeper wounds.

Also, the patch wasn’t compared to skin grafts or flaps—just to open healing. So we don’t know how it stacks up against more advanced techniques.

Still, safety was excellent. No infections. No side effects. High patient ratings. That’s a strong start.

What happens next

Researchers plan larger trials. They’ll test the patch on more patients. They’ll look at different wound sizes and locations.

If results hold, this could become a routine option within a few years. It’s not a miracle. But it could make recovery easier—for thousands facing facial surgery each year.

Healing takes time. But with help from our own bodies, it might not take as long.

Study Details

Study typeRct
Sample sizen = 22
EvidenceLevel 2
Follow-up6.0 mo
PublishedApr 2026
View Original Abstract ↓
Secondary intent healing is a viable option for wound closure after facial tumour removal by Mohs micrographic surgery. Secondary intent healing involves prolonged healing time and carries risk of infection and complications related to scarring. Healing with an autologous patch made from the patient's own blood may be beneficial. This study on 22 patients evaluates the effect of applying an autologous patch to the wound after Mohs micrographic surgery. A randomized controlled assessor-blinded trial was carried out. Patients had Mohs micrographic surgery on day 0 and clinical evaluation on day 12, day 19, and after 6 months. Transepidermal water loss was measured on day 12 and day 19. Reflectance confocal microscopy was applied exploratively. At 6 months' follow-up the Patient and Observer Scar Assessment Scale was evaluated. Primary outcome was fully epithelialized wounds on day 19 and secondary outcome was 50% epithelialized wounds on day 12. One wound from each group was fully epithelialized and wound area reduction was higher in the patch group although not significant. Transepidermal water loss decreased to a larger extent, indicating that the patch creates a moist environment. Wound healing with an autologous patch is equivalent to secondary intent healing but may prompt benefits in certain wound healing factors. Patch healing appears safe with high patient satisfaction.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.